Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Evozyne
Evozyne is a biotechnology company that creates novel protein systems aimed at solving longstanding challenges in therapeutic development. By leveraging advanced protein design and generative AI,…
Evozyne
Evozyne is a biotechnology company that creates novel protein systems aimed at solving longstanding challenges in therapeutic development. By leveraging advanced protein design and generative AI,…
TL;DR
Headquarters: Chicago, Illinois
Founded: 2020
Core tech: Generative AI (EvoGen) + high-throughput experimental biology (EvoLab)
Focus: De novo therapeutic protein design for immune-mediated diseases
Reported funding: Approximately $144.4M (across 3 rounds); Series B on 2023-09-27
Company Overview
Problem Domain
Therapeutic protein design for immune-mediated and IgG-mediated diseases, including indications like inflammatory bowel disease.
Founded
2020
Industry
Biotechnology
Funding Track Record
Reported as most recent round; Crunchbase lists total of three rounds aggregating ~$144.4M.
Investor Signal
“Backed by institutional investors including Fidelity, OrbiMed, Valor Equity Partners, Paragon Biosciences”
Founders
What we do
Join the Team
Startup jobs. A lot of them.
Your next opportunity is in here somewhere. Sign up to explore 52,000+ startups and their open roles. No spam. No gamification. Just jobs.
52,000+
Startups
66,000+
Open Roles
1,500+
New This Week
Related Companies
| Company |
|---|
 |
 |
 |
 |
 |